A Systems Biology Roadmap to Decode mTOR Control System in Cancer

被引:27
作者
Dorvash, Mohammadreza [1 ,2 ]
Farahmandnia, Mohammad [2 ]
Tavassoly, Iman [3 ]
机构
[1] Shiraz Univ Med Sci, Pharmaceut Sci Res Ctr, Shiraz, Iran
[2] Shiraz Univ Med Sci, Fac Med, Cell & Mol Med Student Res Grp, Shiraz, Iran
[3] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, 1425 Madison Ave, New York, NY 10029 USA
关键词
Aging; Bistability; Cancer; Cell fate; Dynamic modeling; Mathematical models; mTOR; Oscillations; Signaling network; Systems biology; CIRCADIAN AUTOPHAGY RHYTHM; MESSENGER-RNA; MAMMALIAN TARGET; APPROACH REVEALS; DIURNAL RHYTHMS; STEM-CELLS; INHIBITORS; NETWORK; RAPAMYCIN; PATHWAY;
D O I
10.1007/s12539-019-00347-6
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mechanistic target of rapamycin (mTOR) is a critical protein in the regulation of cell fate decision making, especially in cancer cells. mTOR acts as a signal integrator and is one of the main elements of interactions among the pivotal cellular processes such as cell death, autophagy, metabolic reprogramming, cell growth, and cell cycle. The temporal control of these processes is essential for the cellular homeostasis and dysregulation of mTOR signaling pathway results in different phenotypes, including aging, oncogenesis, cell survival, cell growth, senescence, quiescence, and cell death. In this paper, we have proposed a systems biology roadmap to study mTOR control system, which introduces the theoretical and experimental modalities to decode temporal and dynamical characteristics of mTOR signaling in cancer.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [31] Engineering Simulations for Cancer Systems Biology
    Bown, James
    Andrews, Paul S.
    Deeni, Yusuf
    Goltsov, Alexey
    Idowu, Michael
    Polack, Fiona A. C.
    Sampson, Adam T.
    Shovman, Mark
    Stepney, Susan
    CURRENT DRUG TARGETS, 2012, 13 (12) : 1560 - 1574
  • [32] Omics/systems biology and cancer cachexia
    Gallagher, Iain J.
    Jacobi, Carsten
    Tardif, Nicolas
    Rooyackers, Olav
    Fearon, Kenneth
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2016, 54 : 92 - 103
  • [33] Systems biology and the molecular circuits of cancer
    Alberghina, L
    Chiaradonna, F
    Vanoni, M
    CHEMBIOCHEM, 2004, 5 (10) : 1322 - 1333
  • [34] Cancer stem cells: a systems biology view of their role in prognosis and therapy
    Mertins, Susan D.
    ANTI-CANCER DRUGS, 2014, 25 (04) : 353 - 367
  • [35] Editorial: Systems Biology and the Challenge of Deciphering the Metabolic Mechanisms Underlying Cancer
    Resendis-Antonio, Osbaldo
    Diener, Christian
    FRONTIERS IN PHYSIOLOGY, 2017, 8
  • [36] Systems Medicine Design based on Systems Biology Approaches and Deep Neural Network for Gastric Cancer
    Yeh, Shan-Ju
    Chen, Bor-Sen
    IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, 2022, 19 (05) : 3019 - 3031
  • [37] The role of kisspeptin system in cancer biology
    Stathaki, Martha
    Stamatiou, Maria Evanthia
    Magioris, George
    Simantiris, Spyridon
    Syrigos, L. Opdotoo Nikolaos
    Dourakis, Spyridon
    Koutsilieris, Michael
    Armakolas, Athanasios
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 142 : 130 - 140
  • [38] Future systems and control research in synthetic biology
    Del Vecchio, Domitilla
    Qian, Yili
    Murray, Richard M.
    Sontag, Eduardo D.
    ANNUAL REVIEWS IN CONTROL, 2018, 45 : 5 - 17
  • [39] The chemokine system in cancer biology and therapy
    Mantovani, Alberto
    Savino, Benedetta
    Locati, Massimo
    Zammataro, Luca
    Allavena, Paola
    Bonecchi, Raffaella
    CYTOKINE & GROWTH FACTOR REVIEWS, 2010, 21 (01) : 27 - 39
  • [40] Requirement of the mTOR Kinase for the Regulation of Maf1 Phosphorylation and Control of RNA Polymerase III-dependent Transcription in Cancer Cells
    Shor, Boris
    Wu, Jiang
    Shakey, Quazi
    Toral-Barza, Lourdes
    Shi, Celine
    Follettie, Max
    Yu, Ker
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (20) : 15380 - 15392